These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 5558109)

  • 21. Natural antibodies in normal human sera againist the Ehrlich mouse ascites tumour identified with the aid of complement components, utilizing classical reagents.
    Oravec C; Cambelová J
    Neoplasma; 1971; 18(2):141-59. PubMed ID: 5577313
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitumor activity of macrophages grown in tumorous ascitic fluid.
    Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
    Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte transformation and macrophage migration in guinea-pigs immunized with Freund's complete adjuvant.
    Ricci M; Romagnani S; Passaleva A; Biliotti G
    Clin Exp Immunol; 1969 Dec; 5(6):659-67. PubMed ID: 5365820
    [No Abstract]   [Full Text] [Related]  

  • 24. Presence of immunosuppressive agents with various activities in Ehrlich ascites fluid.
    Nitta K; Umezawa H
    Gan; 1975 Aug; 66(4):459-60. PubMed ID: 1183781
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG; Bikhunov VL; Zagoruĭko EE
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation and modulation of Ehrlich ascites tumor growth with tumor-plasma IgA.
    Ghosh AK; Saha S
    Indian J Exp Biol; 2000 Apr; 38(4):313-22. PubMed ID: 11218806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 28. Factor(s) from Ehrlich Ascites cells responsible for delayed rejection of skin allografts in mice and its assay on lymphocytes in vitro.
    Gresser I; Vignaux F; Maury C; Lindahl P
    Proc Soc Exp Biol Med; 1975 May; 149(1):83-8. PubMed ID: 1096161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions.
    Yamazaki H; Nitta K; Umezawa H
    Gan; 1973 Feb; 64(1):83-92. PubMed ID: 4577968
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
    Sethi KK; Brandis H
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
    [No Abstract]   [Full Text] [Related]  

  • 32. Diazepam effects on Ehrlich tumor growth and macrophage activity in mice.
    Sakai M; Fonseca ES; Dagli ML; Palermo-Neto J
    Life Sci; 2006 Mar; 78(16):1777-83. PubMed ID: 16257421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the cytotoxic effect of Ehrlich tumor ascites and of a polypeptide isolated there from on tissue cultures].
    Waller M; Coutelle R; Felicetti D; Waller H
    Arch Geschwulstforsch; 1969; 34(2):128-35. PubMed ID: 4920116
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cells of various types activated in vitro by phytohemagglutinin. Target cell lysis].
    Roveta G; Pagani G
    Boll Soc Ital Biol Sper; 1973 Apr; 49(7):357-61. PubMed ID: 4361896
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological evidences for proliferation and migration of lymphocytes induced by administration of potent antitumor phosphomucolipid in tumor-bearing mice.
    Mita A
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):860-7. PubMed ID: 4569609
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of host cells in suppression of the in vivo multiplication of Ehrlich's ascitic cancer cells by the virus-inhibiting factor or interferon].
    Nagano Y; Saito H; Kurashima S; Kumazawa Y
    C R Seances Soc Biol Fil; 1979; 173(5):960-6. PubMed ID: 161194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interactions between macrophages and neoplastic cells in the induction of antitumor immunity].
    Bellelli L
    Boll Soc Ital Biol Sper; 1972 Jul; 48(11):293-4. PubMed ID: 5069602
    [No Abstract]   [Full Text] [Related]  

  • 40. Peritoneal macrophages and neoplastic cells. I. Macrophages activity induced by heavily-irradiated or heat-killed cancer cells.
    Sezzi ML; Bellelli L; Nista A
    Oncology; 1972; 26(6):529-39. PubMed ID: 4648588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.